Scilex Holding Company Shares Outstanding (Cover Page)
Scilex Holding Company (SCLX) had Shares Outstanding (Cover Page) of 8.49 million shares as of 2026-08-10, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-14
- 2026-08-10: Entity Common Stock, Shares Outstanding 8.49M shares.
- 2026-05-15: Entity Common Stock, Shares Outstanding 8.49M shares.
- 2026-04-03: Entity Common Stock, Shares Outstanding 8.49M shares.
- 2025-11-10: Entity Common Stock, Shares Outstanding 7.59M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-10 | 8.49M shares 10-Q · filed 2026-08-14 |
| 2026-05-15 | 8.49M shares 10-Q · filed 2026-05-20 |
| 2026-04-03 | 8.49M shares 10-K · filed 2026-04-10 |
| 2025-11-10 | 7.59M shares 10-Q · filed 2025-11-14 |
| 2025-08-08 | 6.96M shares 10-Q · filed 2025-08-13 |
| 2025-05-09 | 6.95M shares 10-Q · filed 2025-05-14 |
| 2025-03-25 | 243.31M shares 10-K/A · filed 2025-04-29 |
| 2025-01-14 | 243.31M shares 10-Q · filed 2025-01-17 |
| 2024-08-09 | 191.79M shares 10-Q · filed 2024-08-13 |
| 2024-05-09 | 181.19M shares 10-Q · filed 2024-05-13 |
| 2024-03-07 | 166.19M shares 10-K · filed 2024-03-12 |
| 2023-11-09 | 155.94M shares 10-Q · filed 2023-11-14 |
| 2023-08-07 | 149.06M shares 10-Q · filed 2023-08-11 |
| 2023-05-09 | 146.49M shares 10-Q · filed 2023-05-12 |
| 2023-03-03 | 145.80M shares 10-K · filed 2023-03-07 |
| 2022-11-04 | 13.18M shares 10-Q · filed 2022-11-04 |
| 2022-08-12 | 13.18M shares 10-Q · filed 2022-08-12 |
| 2022-05-16 | 17.25M shares 10-Q · filed 2022-05-16 |
| 2022-02-24 | 17.25M shares 10-K · filed 2022-02-24 |
| 2021-12-08 | 17.25M shares 10-Q/A · filed 2021-12-08 |
| 2021-11-10 | 17.25M shares 10-Q · filed 2021-11-10 |
| 2021-08-18 | 17.25M shares 10-Q/A · filed 2021-08-24 |
| 2021-07-23 | 17.25M shares 10-Q · filed 2021-07-23 |
| 2021-03-31 | 17.25M shares 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |